Perioperative treatment with high dose rotigotine and amantadine combination in a patient with advanced stage Parkinson’s disease after esophagectomy
DOI:
https://doi.org/10.2478/AMB-2025-0030Keywords:
esophagus, rotigotine, esophagectomy, Parkinson’s disease, amantadineAbstract
Current treatment for Parkinson’s disease (PD) includes: levodopa, dopamine agonists, monoamine oxidase type B inhibitors, catechol-O-methyltransferase inhibitors, amantadine, anticholinergics, clozapine and deep brain stimulation. A lot of patients with
PD undergo surgery under general anesthesia for abdominal operations with a long fasting period. Interruption of antiparkinsonian drug therapy for long periods of time may worsen the PD symptoms. This is why parenteral substitution of antiparkinsonian medications during the complete fasting period is advised. Herein we present a case of a resistant to usual medication doses PD patient, who underwent total esophagectomy and was treated postoperatively with a combination of high dose rotigotine and amantadine.
References
Kalia LV, Lang AE. Parkinson’s disease. Lancet. 2015;386 (9996):896–912.
Oertel WH. Recent advances in treating Parkinson’s disease. F1000Res. 2017;6(260).
Luckey A, Livingston E, Taché Y. Mechanisms and Treatment of Postoperative Ileus. Arch Surg. 2003;138(2):206–14.
Zheng R, Devin CL, Pucci MJ, et al. Optimal timing and route of nutritional support after esophagectomy: A review of the literature. World J Gastroenterol. 2019;25(31):4427–36.
Daniel M, Al Dhib R, Mendoza M, et al. Understanding and Managing Metabolic Deficiencies Post Bariatric and Esophagectomy Surgeries: A Narrative Review of the Literature. Cureus. 2024;16(5):e60192.
Marical A, Medrano IH, Canovas AA, et al. Perioperative Management of Parkinson’s Disease. Cir Esp. 2011;89(7):427–31.
Wuellner U, Kassubek J, Odin P, et al. Transdermal rotigotine for the perioperative management of Parkinson’s disease. J Neural Transm. 2010;117:855–9.
Broussolle E, Marion MH, Pollak P. Continuous subcutaneous apomorphine as replacement for levodopa in severe parkinsonian patients after surgery. Lancet. 1992; 340(8823):859–60.
Gálvez-Jiménez N, Lang AE. Perioperative problems in Parkinson’s disease and their management: apomorphine with rectal domperidone. Can J Neurol Sci. 1996;23(3):198–203.
Kim YE, Kim HJ, Yun JY, Jeon BS. Intravenous amantadine is safe and effective for the perioperative management of patients with Parkinson’s disease. J Neurol. 2011;258(12):2274–5.
Olanow CW, Espay AJ, Stocchi F, et al. Continuous Subcutaneous Levodopa Delivery for Parkinson’s Disease: A Randomized Study. J Parkinsons Dis. J Parkinsons Dis. 2021;11(1):177–86.
Doggrell SA. Continuous subcutaneous levodopa-carbidopa for the treatment of advanced Parkinson’s disease: is it an improvement on other delivery? Expert Opin Drug Deliv. 2023;20(9):1189–99.
Siddiqi SH, Abraham NK, Geiger CL, et al. The Human Experience with Intravenous Levodopa. Front Pharmacol. 2016;6:307.
Brennan KA, Genever RW. Managing Parkinson’s disease during surgery. BMJ. 2010;341:c5718.
Raz A, Lev N, Orbach-Zinger S, Djaldetti R. Safety of perioperative treatment with intravenous amantadine in patients with Parkinson disease. Clin Neuropharmacol. 2013;36(5):166–9.
Rektor I, Babic T, Boothmann B, et al. High doses of rotigotine transdermal patch: results of an open-label, dose-escalation trial in patients with advanced-stage, idiopathic Parkinson disease. Clin Neuropharmacol. 2009;32(4):193–8.
Goetz CG, Blasucci L, Stebbins GT. Switching Dopamine Agonists in Advanced Parkinson’s Disease: Is Rapid Titration Preferable to Slow? Neurology. 1999;52(6):1227–9.
Chung SJ, Asgharnejad M, Bauer L, et al. Switching From an Oral Dopamine Receptor Agonist to Rotigotine Transdermal Patch: A Review of Clinical Data With a Focus on Patient Perspective. Expert Rev Neurother. 2017;17(7):737–49.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 G. Yankov, V. Ilieva (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
You are free to share, copy and redistribute the material in any medium or format under these terms.
Journal Acta Medica Bulgarica 
